PDCD1 and cancer: Since the PD-1:PD-L1 axis exerts multiple functions within the tumor environment, combinatorial therapeutic approaches allowing for simultaneous manipulation of T cell priming in secondary lymphoid organs and modulation of effector functions in the highly suppressive tumor microenvironment were therefore suggested early to improve cancer therapy.